| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |